Within ForeFront, the Centre of Research Excellence to optimise sleep in Brain Ageing and Neurodegeneration (CogSleep) team brings together sleep researchers, sleep clinicians, neurobiologists, neuroscientists, neurologists and neuropsychologists to understand the role sleep and sleep disorders in the development of neurodegenerative disorders. Sleep is an essential component of healthy brain ageing. Sleep and circadian disturbances are key characteristics in established neurodegenerative diseases including dementia and Parkinson’s disease. There is now growing evidence that sleep disturbance may accelerate neurodegeneration and cognitive decline and increases the risk of developing dementia. Using new technologies including remote monitoring of sleep including wearables and bedables; HDEEG, we are assessing the effect of various treatments for sleep disturbance and disorders, such as sleep apnea treatments, digital insomnia therapies and melatonin and their effect on cognition and markers of neurodegeneration.